Published in Surg Endosc on December 24, 2009
Risk factors affecting operative approach, conversion, and morbidity for adrenalectomy: a single-institution series of 402 patients. Surg Endosc (2013) 1.06
The effect of surgical treatment of phaeochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single-centre retrospective study. Cent European J Urol (2014) 0.80
Laparoscopic trans- and retroperitoneal adrenal surgery for large tumors. J Minim Access Surg (2014) 0.75
Preoperative risk factors of hemodynamic instability during laparoscopic adrenalectomy for pheochromocytoma. Surg Endosc (2015) 0.75
Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med (1992) 4.65
Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms. J Am Coll Surg (1996) 2.46
Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32
Laparoscopic adrenalectomy for pheochromocytoma. World J Surg (2002) 1.67
Pheochromocytoma: current status and changing trends. Surgery (1982) 1.44
Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Arch Surg (2002) 1.42
Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery (1997) 1.40
Feasibility of laparoscopic adrenalectomy for large adrenal masses. Surg Laparosc Endosc Percutan Tech (2003) 1.40
Results of laparoscopic adrenalectomy for large and potentially malignant tumors. World J Surg (2002) 1.38
Laparoscopic adrenalectomy. A new standard of care. Ann Surg (1997) 1.37
A comparison of laparoscopic and open adrenalectomies. Arch Surg (1995) 1.35
A case-controlled study of laparoscopic compared with open lateral adrenalectomy. Am J Surg (1999) 1.28
Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery (2005) 1.26
Laparoscopic curative resection of pheochromocytomas. Ann Surg (2005) 1.22
Is laparoscopic adrenalectomy indicated for pheochromocytomas? Surgery (1996) 1.22
Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment? Surgery (2007) 1.17
The positive impact of laparoscopic adrenalectomy on complications of adrenal surgery. Surg Endosc (2001) 1.12
Surgical treatment of pheochromocytomas: laparoscopic or conventional? Surg Endosc (1999) 1.08
Laparoscopic surgery for pheochromocytoma. Eur Urol (2004) 1.06
Adrenalectomy in the era of laparoscopy. Surgery (1996) 1.02
Comparison of the hemodynamic parameters of open and laparoscopic adrenalectomy for pheochromocytoma. World J Surg (2000) 1.02
Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s). World J Surg (1990) 1.01
Analysis of large versus small pheochromocytomas: operative approaches and patient outcomes. Surgery (2006) 1.01
Laparoscopic approach to pheochromocytoma: hemodynamic changes and catecholamine secretion. World J Surg (1996) 1.01
Outcomes for laparoscopic bilateral adrenalectomy. J Laparoendosc Adv Surg Tech A (2002) 1.00
Laparoscopic adrenalectomy for pheochromocytoma. A comparison to aldosteronoma and incidentaloma. Surg Endosc (2004) 0.97
Reasons for conversion from laparoscopic to open or hand-assisted adrenalectomy: review of 261 laparoscopic adrenalectomies from 1993 to 2003. World J Surg (2004) 0.97
Endoscopic treatment of large primary adrenal tumours. Br J Surg (2005) 0.96
Outcome of laparoscopic adrenalectomy for pheochromocytomas vs aldosteronomas. Arch Surg (2004) 0.94
Hypertensive responses during operation for phaeochromocytoma: a study of plasma catecholamine and haemodynamic changes. Eur J Anaesthesiol (1985) 0.80
Safety of laparoscopic adrenalectomy in patients with large pheochromocytomas: a single institution review. World J Surg (2008) 0.80
Laparoscopic adrenalectomy. J Am Coll Surg (1996) 0.77
A comparison of open and laparoscopic approaches to adrenalectomy in patients with phaeochromocytoma. Anaesth Intensive Care (2004) 0.75
Biologic prosthesis to prevent recurrence after laparoscopic paraesophageal hernia repair: long-term follow-up from a multicenter, prospective, randomized trial. J Am Coll Surg (2011) 3.14
Cushing's syndrome might be underappreciated in patients seeking bariatric surgery: a plea for screening. Surg Obes Relat Dis (2008) 2.24
Symptomatic venous thromboembolism after femoral vein harvest. J Vasc Surg (2012) 1.99
Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg (2002) 1.94
Laparoscopic paraesophageal hernia repair: defining long-term clinical and anatomic outcomes. J Gastrointest Surg (2012) 1.89
Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience. Ann Surg (2007) 1.81
Predictors of technical skill acquisition among resident trainees in a laparoscopic skills education program. World J Surg (2008) 1.62
Decreased conduit perfusion measured by spectroscopy is associated with anastomotic complications. Ann Thorac Surg (2011) 1.49
Splenectomy for immune thrombocytopenic purpura: surgery for the 21st century. Am J Hematol (2008) 1.47
Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS One (2012) 1.43
Forty-eight-hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure. J Gastrointest Surg (2005) 1.27
Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era? J Am Coll Surg (2009) 1.18
Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005-2008. J Gastrointest Surg (2010) 1.15
Quality of life after laparoscopic bilateral adrenalectomy for Cushing's disease. Surgery (2002) 1.14
Comparison of perioperative outcomes after combined thoracoscopic-laparoscopic esophagectomy and open Ivor-Lewis esophagectomy. Am J Surg (2010) 1.06
The national mortality burden and significant factors associated with open and laparoscopic cholecystectomy: 1997-2006. J Gastrointest Surg (2009) 1.03
Patient and hospital characteristics on the variance of perioperative outcomes for pancreatic resection in the United States: a plea for outcome-based and not volume-based referral guidelines. Arch Surg (2009) 1.00
Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis. Cancer (2010) 1.00
N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence. Proc Natl Acad Sci U S A (2012) 1.00
Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable? Am J Surg (2007) 0.97
An update: the operative experience in adrenal, pancreatic, and other less common endocrine diseases of U.S. general surgery residents. World J Surg (2008) 0.96
Cancers of the gallbladder and biliary ducts. Oncology (Williston Park) (2002) 0.96
Effects of Helicobacter pylori on intracellular Ca2+ signaling in normal human gastric mucous epithelial cells. Am J Physiol Gastrointest Liver Physiol (2003) 0.95
Laparoscopic and open distal pancreatic resection for benign pancreatic disease. J Gastrointest Surg (2007) 0.95
Adrenal and pancreatic presentation of subdiaphragmatic retroperitoneal bronchogenic cysts. Arch Surg (2010) 0.95
Techniques and results of portal vein/superior mesenteric vein reconstruction using femoral and saphenous vein during pancreaticoduodenectomy. J Vasc Surg (2010) 0.94
Institute of medicine committee report on resident duty hours: a view from a trench. J Grad Med Educ (2009) 0.94
Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer. Surg Endosc (2013) 0.92
Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma. Arch Surg (2011) 0.91
Comparison of laparoscopic inversion esophagectomy and open transhiatal esophagectomy for high-grade dysplasia and stage I esophageal adenocarcinoma. Arch Surg (2009) 0.91
Management of long-term failure after colon interposition for benign disease. Am J Surg (2002) 0.90
The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma. Hum Pathol (2012) 0.88
Reconstruction of the jejunoesophageal anastomosis with a circular mechanical stapler in total laryngopharyngectomy defects. Head Neck (2011) 0.88
2014 SSAT State-of-the-Art Conference: advances in diagnosis and management of gastroesophageal reflux disease. J Gastrointest Surg (2014) 0.88
Predicting malignant intraductal papillary mucinous neoplasm: a single-center review. Am J Surg (2011) 0.87
Diagnosis and management of blunt pancreatic ductal injury in the era of high-resolution computed axial tomography. Am J Surg (2007) 0.87
Clostridium difficile enteritis: A report of two cases and systematic literature review. World J Gastrointest Surg (2013) 0.83
Disparities in the treatment of colon cancer in octogenarians. Am J Surg (2009) 0.83
Bile duct injury after laparoscopic cholecystectomy in hospitals with and without surgical residency programs: is there a difference? Surg Endosc (2010) 0.83
Suprarenal retroperitoneal liposarcoma with intracaval tumor thrombus: an imaging mimic of adrenocortical carcinoma. Clin Imaging (2013) 0.82
Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis. Am J Surg (2008) 0.81
Esophageal replacement following gastric devascularization is safe, feasible, and may decrease anastomotic complications. J Gastrointest Surg (2010) 0.80
Helicobacter pylori induces apoptosis in Barrett's-derived esophageal adenocarcinoma cells. J Gastrointest Surg (2003) 0.79
Bile duct involvement portends poor prognosis in resected gallbladder carcinoma. Gastrointest Cancer Res (2013) 0.78
Lymph Node Harvest During Esophagectomy Is Not Influenced by Use of Neoadjuvant Therapy or Clinical Disease Stage. J Gastrointest Surg (2015) 0.78
Retained common bile duct stone as a consequence of a fundus-first laparoscopic cholecystectomy. J Laparoendosc Adv Surg Tech A (2005) 0.78
Endoscopic ultrasound may be unnecessary in the preoperative evaluation of intraductal papillary mucinous neoplasm. HPB (Oxford) (2010) 0.78
Optical fiber probe spectroscopy for laparoscopic monitoring of tissue oxygenation during esophagectomies. J Biomed Opt (2011) 0.77
Increased vascular endothelial growth factor transcription in residual hepatocellular carcinoma after open versus laparoscopic hepatectomy in a small animal model. Surg Endosc (2009) 0.77
A suitable animal model for laparoscopic hepatic resection training. Surg Endosc (2007) 0.77
New approaches to the minimally invasive treatment of pancreatic cancer. Cancer J (2005) 0.76
Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer. Dis Colon Rectum (2016) 0.76
Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy. J Gastrointest Surg (2013) 0.75
Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia. Cancer Cytopathol (2012) 0.75
Feasibility of subcutaneous gentamicin and pressurized irrigation as adjuvant strategies to reduce surgical site infection in colorectal surgery: results of a pilot study. Am Surg (2015) 0.75
Evaluation of endoscopic full-thickness plication on anti-reflux valve competency. J Surg Educ (2008) 0.75
Surgical complications of bone marrow transplantation. Am J Surg (2003) 0.75
The adrenal psoas sign: surgical outcomes following a simple technique to maximize removal of extracortical adrenal tissue during bilateral laparoscopic adrenalectomy. Surg Endosc (2014) 0.75
Communicating esophageal duplication with Barrett's esophagus and high-grade dysplasia. Surgery (2002) 0.75
Outcome following surgical therapy for gastrointestinal stromal tumors. J Gastrointest Surg (2006) 0.75